Yuko Miyagawa

No ORCID on file · 3 papers in corpus
observational 2024
Journal of ovarian research ·doi:10.1186/s13048-024-01494-1

BACKGROUND: Interval debulking surgery (IDS) following neoadjuvant chemotherapy is a treatment option for advanced ovarian cancer. Optimal surgery is required for better survival; however, while peritoneal washing cytology (PWC) has been id…

lab-animal 2021
Heliyon ·doi:10.1016/j.heliyon.2021.e08696

Ulipristal acetate (UPA), a selective progesterone receptor modulator, is used for the treatment of uterine fibroids and selectively inhibits the proliferation and inflammation of leiomyoma cells. As few studies have focused on the molecula…

2021
·doi:10.2139/ssrn.3884693